Biogen Australia Pty Ltd - Company Review
Biogen Australia Pty Ltd - Company ReviewSummary
Biogen Australia Pty Ltd (Biogen Australia), a subsidiary of Biogen, Inc. is a pharmaceutical company that discovers, develops, manufactures and commercializes innovative therapies for the treatment of multiple sclerosis and hemophilia A and B. Its product portfolio includes AVONEX, PLEGRIDY, TECFIDERA and TYSABRI for multiple sclerosis; and ELOCTATE and ALPROLIX for the treatment of hemophilia. The company’s target therapy areas include neurology, immunology and haematology. Biogen Australia partners with healthcare providers, health consumer organisations, government and local communities. The company offers products and services to patients and healthcare providers. It was formerly known as Biogen Idec Australia Pty Ltd. Biogen Australia is headquartered in North Ryde, New South Wales, Australia.
This comprehensive company report of Biogen Australia Pty Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.